The neuronal nitric oxide synthase (nNOS) has been successfully overexpressed in Escherichia coli, with average yields of 125-150 nmol (20-24 mg) of enzyme per liter of cells. The cDNA for nNOS was subcloned into the pCW vector under the control of the tac promotor and was coexpressed with the chaperonins groEL and groES in the protease-deficient BL21 strain ofE. coli. The enzyme produced is replete with heme and flavins and, after overnight incubation with tetrahydrobiopterin, contains 0.7 pmol of tetrahydrobiopterin per pmol of nNOS. nNOS is isolated as a predominantly high-spin heme protein and demonstrates spectral properties that are identical to those of nNOS isolated from stably transfected human kidney 293 cells. It binds N'0-nitroarginine dependent on the presence of bound tetrahydrobiopterin and exhibits a Kd of 45 nM. The enzyme is completely functional; the specific activity is 450 nmol/min per mg. This overexpression system will be extremely useful for rapid, inexpensive preparation of large amounts of active nNOS for use in mechanistic and structure/function studies, as well as for drug design and development.
Nitric oxide synthase (NOS) catalyzes the formation of NO' and L-citrulline from L-arginine through a series of oxidations using molecular oxygen (1) . There are three separate genes known to encode the NOS family of proteins, including the constitutively expressed neuronal (nNOS) (2) and endothelial cell (ecNOS) (3, 4) isoforms and the inducible isoform (iNOS) (5, 6) . The product of the NADPH-mediated reaction, NO, has been implicated in neurotransmission in the brain and in neuromuscular junctions (nNOS), hemodynamic regulation (ecNOS), and cytotoxicity (iNOS). The effects of NO produced by the nNOS and ecNOS are thought to be mediated through stimulation of guanylate cyclase activity, whereas the NO produced by iNOS appears to act directly or via peroxynitrite on foreign cells (for reviews, see refs. 7 
and 8).
The three isoforms differ in primary sequence, having only 50-60% sequence identity (9) , size, intracellular location, and regulation. nNOS (160 kDa) and iNOS (130 kDa) were purified from the cytosol (8, (10) (11) (12) , whereas the ecNOS (135 kDa) was found to be membrane-bound (13) . The nNOS and ecNOS are constitutively expressed but modulated by intracellular Ca2+ levels (1, 14) , unlike iNOS, which is induced by bacterial endotoxin and is Ca2+-independent (15) . All three isoforms bind calmodulin and tetrahydrobiopterin (BH4), as well as molar ratios of heme, FMN, and FAD (11) (12) (13) (16) (17) (18) (19) (20) . These members of the NOS family are the only mammalian enzymes that catalyze both hydroxylation and NADPH reduction of flavins within the same protein, an attribute shared only by the Bacillus megaterium enzyme, cytochrome P450BM-3 (21) .
Mechanistic and structure/function studies of nNOS had initially been very difficult due to the minute amounts of protein that can be purified from cerebellar tissue. Bredt and Snyder (1) , who initially isolated nNOS, reported a yield of 9 ,ug of pure protein from 18 rat brains. Bredt et al. (2) subsequently cloned and expressed nNOS in human kidney 293 cells, providing a 10-fold enrichment of nNOS in cultured cells over rat brain. Twelve liters of these cultured cells consistently yield 8-10 mg of nNOS (K. McMillan and B.S.S.M., unpublished observation). Although this is a significant improvement over initial yields, the expense and time involved in mammalian cell culture are extensive. Other laboratories have expressed nNOS using baculovirus overexpression systems. Charles et al. (22) report successful expression, but the majority of their recombinant nNOS is insoluble and inactive; the recombinant enzyme has a specific activity that is 100-fold lower than that of native nNOS isolated from rat cerebellar tissue. Richards and Marletta (23) improved the yield of active enzyme from the baculovirus system by adding hemin to the medium but still can isolate only -1 mg of pure protein from 7-10 75-cm2 monolayer cultures, only about half of which contains heme.
In this paper, we report the overexpression of active nNOS in Escherichia coli. Expression was directed under the tac promoter of the PCWori+ vector, a system that has been instrumental in the expression of cytochromes P450 (24, 25) . This vector was chosen to promote the proper insertion of heme, as occurs for E. coli-expressed cytochromes P450, in an effort to abate a major drawback of the baculoviral system, poor heme incorporation. Because initial experiments were plagued by highly proteolyzed and dysfunctional protein, an expression plasmid for the chaperonins groEL and groES (26) was also included. (27) , containing groEL and groES cDNAs, was from Abbreviations: NOS, nitric oxide synthase; nNOS, neuronal isoform of NOS; ecNOS, endothelial cell isoform of NOS; iNOS, inducible macrophage isoform of NOS; BH4, tetrahydrobiopterin; NNA, N@-nitro-L-arginine; NMA, N-methyl-L-arginine.
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Paul Horowitz at The University of Texas Health Science Center at San Antonio. pCWori+ (28) DNA was digested with Nde I and Xba I, and the ends were dephosphorylated. The three pieces were ligated, and the resultant products were used to transform E. coli. JM109 competent cells were purchased from Stratagene and transformed by using the manufacturer's instructions.
The transformation mixture was plated on LB agar containing ampicillin at 50 ,ug/ml, and nine colonies were screened by BamHI restriction digest of alkaline lysis plasmid minipreparations. Five positive clones were further screened for isopropyl j3-D-thiogalactoside-induced (0.5 mM, added at OD600 = 0.8, along with 225 ,uM 8-aminolevulinic acid) expression of nNOS at 37°C by immunoblot analysis of whole cells using rabbit anti-rat nNOS IgG. All five clones exhibited bands that comigrated with that of nNOS isolated from kidney 293 cells.
In subsequent manipulations, when pGroELS was cotransformed with nNOSpCW, transformants were plated on LB agar containing ampicillin at 50 ,ug/ml and chloramphenicol at 35 jig/ml. Due to severe proteolysis of nNOS when JM109 cells were lysed, both plasmids were also cotransformed into the protease-deficient E. coli strain BL21. Transformation of BL21 was via electroporation using an Invitrogen electroporator II according to manufacturer's instructions.
Protein Expression. Fernbach flasks containing 1 liter of modified Terrific Broth (20 g of yeast extract, 10 g of bactotryptone, 2.65 g of KH2PO4, 4.33 g of Na2HPO4, and 4 ml of glycerol) and ampicillin at 50 ,8g/ml and, when pGroELS was present, chloramphenicol at 35 ,tg/ml were inoculated with 1 ml of an overnight culture (grown in LB plus antibiotics) and shaken at 250 rpm at 37°C. Protein expression was induced at OD600 = 1.0-1.4 with the addition of isopropyl P-Dthiogalactoside to 0.5 mM. The heme and flavin precursors, 8 -aminolevulinic acid and riboflavin, were also added to final concentrations of 450 ,uM and 3 ,uM, respectively. When pGroELS was present, the culture medium also contained 1 mM ATP. The flasks were moved to room temperature (25°C) and shaken in the dark at 250 rpm. The cells were harvested at =40 hr after induction, and the cell paste was frozen at -80°C until purification.
JM109 cells containing pNOSpCW grown after induction at 37°C exhibit no detectable peak at 445 nm in CO difference spectra; all protein is present as a 420-nm species. JM109 cells containing pNOSpCW grown at 25°C for 36-40 hr after induction have both 445-and 420-nm species; this protein is heavily proteolyzed upon cell lysis, as judged by immunoblot analysis. The absolute amount of protein production in JM109 cells is enhanced 5-to 10-fold upon coexpression of nNOS with groEL and groES, but this protein is still heavily proteolyzed upon cell lysis. A small amount of activity (1% that of nNOS purified from 293 cells, data not shown) can be detected. BL21 cells containing pNOSpCW do not appear to express nNOS as detectable by CO difference spectra. BL21 cells containing both pNOSpCW and pGroELS, however, produce 125-150 nmol of nNOS (20-24 mg) per liter of culture, as quantitated by CO difference spectra. All data presented in this paper are derived using protein purified from BL21 that has been cotransformed with both pNOSpCW and pGroELS.
Protein Purification. Harvested cells were resuspended in 30 ml of resuspension buffer (100 mM Tris HCl, pH 7.4/1 mM EDTA/1 mM dithiothreitol/10% (vol/vol) glycerol/i mM phenylmethylsulfonyl fluoride/leupeptin at S ,ug/ml/pepstatin at 5 ,tg/ml per liter of initial culture and were lysed by pulsed sonication (4 min, 80% power, large probe, Fisher Scientific model 550). Cell debris was removed by centrifugation at 150,000 x g for 70 min. The supernatant was applied to a 2',5'-ADP-Sepharose 4B column (6 ml, Pharmacia) equilibrated in buffer B (50 mM Tris HCI, pH 7.4/0.1 mM EDTA/ 0.1 mM dithiothreitol/10% glycerol/100 mM NaCI). The column was extensively washed with at least 10 column volumes of buffer B and then washed again with buffer B/500 mM NaCl. The protein was eluted with buffer B/500 mM NaCl/5 mM 2'-AMP. The colored fractions were pooled and concentrated (Centriprep 30, Amicon), and L-arginine and BH4 were added to final concentrations of 2 mM and 1 mM, respectively. This fraction was incubated overnight at 4°C and applied to a S-200 gel filtration column (480 ml, 2.5-cm diameter, Pharmacia) equilibrated in buffer B. The nNOS-containing fractions were pooled, concentrated, and stored at -80°C. All manipulations were done at 4°C. The cytosolic extract contains 125-150 nmol of nNOS (100% yield), as determined by CO difference spectra, the 2',5'-ADP-Sepharose 4B column pool contains 50-100 nmol of enzyme (-55% yield), and the S-200 column pool contains 25-45 nmol of enzyme (=30%). Enzymatic activity, as measured by the conversion of L-arginine to L-citrulline (see below), parallels the heme content. Optimization of this purification procedure may further increase these yields. The ratio of heme to FMN content was determined to be 1:1. The concentrations of the flavins were determined by using the method of Faeder and Siegel (29 (Fig. 1, lane 6) . Spectrophotometric Methods. Absolute spectra and CO difference spectra were done essentially as described by McMillan and Masters (30) except that all measurements were done in buffer B, and the CO difference spectra were obtained by reducing the protein and then bubbling the sample cuvette with CO. Substrate perturbation difference spectra were done as described (30) , but in the presence of 1 mM imidazole to shift the entire population of nNOS to the low-spin heme state. The molar protein concentration was determined based on heme content and AE4475 = 75 mM-1 (18, 31) . All spectral analyses were performed by using a Shimadzu model 2101 UV/visible dual-beam spectrophotometer.
Measurement of NO Formation. Nitric oxide formation was measured by using both the hemoglobin capture assay (32) , done at 25°C as described by Sheta et al. (33) and the method of Bredt and Snyder (1), which monitors the formation of L-[3H]citrulline from L-[3H]arginine, as described (19) . Each reaction mixture, containing 0.5 ,xg of enzyme, was incubated at 25°C for 2 min (over which time the reaction is linear). For Km analysis, the concentration of L-[3H]arginine in the reaction mixture was varied over the range of 2.0-10.0 ,uM.
Pterin Analysis. Determination of pterin content was done as described by Gross and Levi (34) , based on the method of Fukushima and Nixon (35) , by acid hydrolysis of a 10-ng protein sample followed by quantitation of pterin by C18 reverse-phase HPLC.
Determination of NO-nitro-L-arginine (NNA)-Binding Constant. The NNA-binding constant was determined by direct titration of purified nNOS with [3H]NNA. In these experiments, done in 96-well poly(vinylidene difluoride) plates in 100-,lI total volume, 10 pmol of nNOS and radiolabeled NNA (specific activity -23,000 dpm/pmol) were incubated at room temperature for 15 min in 50 mM Tris HCl, pH 7.6/1 mM dithiothreitol, in the presence or absence of 10 ,uM BH4. Assays were also done in the presence or absence of 100 ,uM N-methyl-L-arginine (NMA), a potent inhibitor of L-arginine binding. The incubation was stopped by aspiration of the sample through the poly(vinylidene difluoride) membrane. The wells were washed twice with 200 ,l of 50 mM Tris, pH 7.6, and air-dried for 10 min; 25 1.l of scintillation cocktail was added, and radioactivity of samples was counted.
Determination of Heme Content. The heme content of the purified protein preparation was measured by CO difference spectra (described above) and by the pyridine hemochromogen method (36) . A 30-,lA aliquot of pyridine was added to 70 ,ul of purified protein, along with 1.5 ,ul of 10 M NaOH. The sample was reduced with two grains of dithionite, and the spectrum was read after 2 min. Heme concentration was determined by the absorbance at 556 nm, assuming s = 34 mM-1.
RESULTS
Spectral Characteristics of Purified E. coli-Expressed Enzyme. Fig. 2 shows the absolute spectrum of nNOS isolated from E. coli. It exhibits a broad peak at 400 nm and secondary maxima at 550 and 650 nm, indicative of a predominantly high-spin heme, although some low-spin form is present, as evidenced by the shoulder at 410 nm. Shoulders are also apparent at 450 and 475 nm and are due to flavin absorbance; this spectrum is identical to that of nNOS isolated from human kidney 293 cells (19) . As shown in Fig. 2 , the maximum heme absorbance at 400 nm can be shifted to the low-spin form (peak at 428 nm) by the addition of imidazole to 1 mM or completely to the high-spin form (peak at 395 nm) by the addition of arginine to 2 ,uM. Fig. 2 Inset also shows the characteristic cytochrome P450-like CO difference spectrum of nNOS with a peak at 444 nm. The molar concentration of heme-containing enzyme, calcu- Absolute absorbance and CO difference spectra of nNOS as purified from E. coli. Experiments were done as described using 3.2 ,uM nNOS. Curve: a, unperturbed spectrum of purified nNOS; b, spectrum after addition of 1 mM imidazole to nNOS; and c, spectrum after addition of 2 ALM L-arginine to nNOS. (Inset) CO difference spectra, using 1.9 ,uM nNOS.
lated from the peak at 444 nm, assuming A8444-475 = 75 mM-, is 1.9 ,uM. For comparison, a pyridine hemochromogen was also done to determine the heme concentration (data not shown); this method yielded a concentration of 2.1 ,AM, in reasonable agreement with that calculated from the CO difference spectrum.
With the technique of difference spectrophotometry, the perturbation of the heme spectrum by increments of Larginine, in the presence of 1 mM imidazole, was measured (Fig. 3) . A type I spectrum, characterized by a maximum at -390 nm and a minimum at -430 nm, was observed. Proc. Natl. Acad. Sci. USA 92 (1995) Proc. Natl. Acad. Sci. USA 92 (1995) 8431 1 contains 0.096 pmol of BH4 per pmol of nNOS-i.e., 10% of the expressed nNOS contains BH4 (data not shown). No other pterin moiety was present. This is in contrast to the nNOS heme domain expressed in E. coli JM109, which contained only 1-2% BH4, as well as being -30% saturated with non-BH4 pterin (K McMillan, S.S.G., and B.S.S.M., unpublished observation). Fraction 2 was complemented with 0.636 pmol of BH4 per pmol of nNOS-i.e., 64% saturated (data not shown). Thus, if stoichiometric binding of BH4 is required for activity, this preparation of nNOS contains 64% active enzyme.
Binding of NNA to Purified E. coli-Expressed Enzyme. The binding of [3H]NNA as a function of ligand concentration was determined in the presence and absence of additional BH4 for both fractions 1 (pre-BH4) and 2 (post-BH4). Fig. 4 shows that NNA binds significantly to E. coli-expressed nNOS fraction 1 (circles) only in the presence of added BH4. In addition, fraction 1 enzyme can be reconstituted with BH4 up to 54%, and fraction 2 enzyme does not bind additional BH4-i.e., it appears to be maximally complemented. Enzymatic Activity of Purified E. coli-Expressed Enzyme. The conversion of L-arginine to L-citrulline was assayed for fractions 1 (pre-BH4) and 2 (post-BH4) in the presence and absence of additional BH4. The turnover numbers for fraction 1 were 75 and 202 nmol/min per mg without and with BH4 in the assay mixture, respectively, a stimulation of 2.7-fold. The turnover numbers for fraction 2 were 189 and 435 nmol/min per mg without and with BH4 in the assay mixture, respectively, a stimulation of 2.3-fold. The enzymatic activity is inhibited by 95% by 100 ,tM NMA in all cases; this is consistent with the inhibition of NNA binding by NMA. The turnover numbers for both fractions in the presence of BH4 were confirmed by using the hemoglobin capture assay; the activities of fractions 1 and 2 were 239 and 468 nmol/min per mg, respectively, demonstrating excellent agreement between the two methods. These turnover numbers are very similar to those obtained with nNOS purified from human kidney 293 cells in which activities between 300 and 450 nmol/min per mg are typically observed.
The Km value for L-arginine was determined to be 2.8 JIM for E. coli-purified nNOS (data not shown). Concomitant measurement using human kidney 293 cell-purified nNOS yielded a Km value of 1.9 ,uM. These values are in excellent agreement with each other and with the Km value of 2 ,uM for nNOS reported by Bredt and Snyder (1) and McMillan et al. (19) .
DISCUSSION
We have developed a method for the overexpression of nNOS in E. coli, a system that offers a quick and inexpensive way to produce large quantities of active enzyme. We can produce 125-150 nmol (20-24 mg) of nNOS per liter of E. coli culture. The three elements composing this successful method are the vector used (pCW), the coexpression of chaperonins with nNOS, and the E. coli strain in which the proteins are expressed (BL21). It is intriguing that a simple prokaryotic system such as E. coli has the ability to overexpress as complex a mammalian enzyme as nNOS, which contains protoporphyrin IX heme, FAD, FMN, and BH4 as prosthetic groups. The lack of calmodulin produced in this system is an advantage in that the nNOS is not activated to produce cytotoxic NO.
The production of nNOS is controlled by the tac promoter of pCW, an expression vector chosen because it has proved to be invaluable for the expression of cytochromes P450 (24, 25) , a family of enzymes to which the N-terminal domain of nNOS has been compared, as well as cytochrome P450/NADPHcytochrome P450 reductase fusion proteins (38, 39) , chimeric constructs that mimic the activities of hydroxylase and reductase domains in a single protein.
The heme moiety appears to be inserted correctly into the majority of expressed nNOS protein, as judged by the absolute and CO difference spectra and the spectral perturbation by the substrate L-arginine. The lack of heme repletion, which seems to be a major drawback of the expression of NOS in a baculovirus system (22, 23) , is overcome by expression in E. coli.
In the current report, nNOS is coexpressed with the E. coli groE molecular chaperonin system (groEL and groES). In (26, 40) . The observation that substantially more nNOS is produced in the presence of chaperonins further demonstrates the usefulness of this approach.
E. coli strain JM109 was initially chosen for the expression of nNOS but, upon lysis of the cells, the calmodulin-binding site proved extremely susceptible to proteolytic attack. As a result of this sensitivity, large amounts of the proteolytically produced domains of E. coli-expressed nNOS were initially purified, a problem that was alleviated by coexpressing the nNOS and chaperonins in BL21, a strain reported to be lacking both lon and ompT proteases.
The nNOS enzyme produced by E. coli appears indistinguishable, in all respects examined, from that produced by nNOS stably transfected human kidney 293 cells; the absolute spectrum and its perturbation by the substrate L-arginine (spectral binding constant '717 nM), the CO difference spectrum, and the specific activity of E. coli-expressed nNOS and mammalian cell-expressed nNOS are identical. The bind- (19) and that reported by Bredt and Snyder (1) for nNOS isolated from rat brain (-2 ,uM). The observation that fraction 2 seems to be fully complemented with BH4 and yet BH4 added to the assay increases activity significantly is interesting; perhaps the BH4 bound to the enzyme is unstable or destroyed during catalysis. The difference between the activities exhibited by the pre-and post-BH4 fractions, however, is 2-fold whether or not BH4 is included in the assay; it appears that the earlier the nNOS is saturated with BH4, the higher the activity-i.e., the more stable the enzyme.
The large amounts of intact, active nNOS, which has a specific activity at least as high as that of kidney 293 cellexpressed enzyme, that can be generated using this system will make possible mechanistic, kinetic, and spectroscopic studies leading to the understanding of structure/function relationships. The approach outlined here may also be useful for the overexpression of the other NOS isoforms, ecNOS and iNOS, in E. coli. This overexpression system also provides a source of nNOS that is essentially BH4-free for analysis of BH4 function in NOS catalysis. The availability of this quantity of the NOS enzyme will be extremely useful for site-directed mutagenesis and, given the important physiological roles played by the NOS isoforms, drug design and development.
